An Observational Study to Evaluate Neoadjuvant Nivolumab (OPDIVO®) in Combination With Platinum-Based Chemotherapy in Non-Metastatic Non-Small Cell Lung Cancer Participants in Germany
Clinical trial NCT06169956 · RECRUITING
Trial details
- NCT number
- NCT06169956
- Sponsor
- Bristol-Myers Squibb
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-11-30
- Primary completion
- 2030-09-30
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.